Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CSPHF - Week In Review: Fosun Pays $158 Million For Controlling Stake In Singapore Medical Centers


CSPHF - Week In Review: Fosun Pays $158 Million For Controlling Stake In Singapore Medical Centers

  • Shanghai Fosun Pharma will pay $158 million to acquire a 60% stake in a Singapore oncology medical center chain, Oncocare Medical Pte.
  • OnCusp Therapeutics, a New York-Shanghai biopharma, acquired global rights (ex-China) to a pre-clinical CDH6 antibody drug conjugate from Multitude Therapeutics.
  • Chengdu Keymed Biosciences dosed the first patient in a China Phase I trial of a bispecific antibody that targets solid tumors.

For further details see:

Week In Review: Fosun Pays $158 Million For Controlling Stake In Singapore Medical Centers
Stock Information

Company Name: CStone Pharmaceuticals - Ordinary Shares
Stock Symbol: CSPHF
Market: OTC

Menu

CSPHF CSPHF Quote CSPHF Short CSPHF News CSPHF Articles CSPHF Message Board
Get CSPHF Alerts

News, Short Squeeze, Breakout and More Instantly...